BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 19949037)

  • 1. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
    Teunissen CE; Petzold A; Bennett JL; Berven FS; Brundin L; Comabella M; Franciotta D; Frederiksen JL; Fleming JO; Furlan R; Hintzen RQ; Hughes SG; Johnson MH; Krasulova E; Kuhle J; Magnone MC; Rajda C; Rejdak K; Schmidt HK; van Pesch V; Waubant E; Wolf C; Giovannoni G; Hemmer B; Tumani H; Deisenhammer F
    Neurology; 2009 Dec; 73(22):1914-22. PubMed ID: 19949037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
    Teunissen CE; Tumani H; Bennett JL; Berven FS; Brundin L; Comabella M; Franciotta D; Federiksen JL; Fleming JO; Furlan R; Hintzen RQ; Hughes SG; Jimenez CR; Johnson MH; Killestein J; Krasulova E; Kuhle J; Magnone MC; Petzold A; Rajda C; Rejdak K; Schmidt HK; van Pesch V; Waubant E; Wolf C; Deisenhammer F; Giovannoni G; Hemmer B
    Mult Scler Int; 2011; 2011():246412. PubMed ID: 22096631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
    Teunissen CE; Tumani HT; Bennett JL; Berven FS; Brundin L; Comabella M; Franciotta D; Federiksen JL; Fleming JO; Furlan R; Hintzen RQ; Hughes SG; Johnson MH; Krasulova E; Kuhle J; Magnone MC; Petzold A; Rajda C; Rejdak K; Schmidt HK; van Pesch V; Waubant E; Wolf C; Hemmer B; Deisenhammer F; Giovannoni G
    Mult Scler; 2010 Feb; 16(2):129-32. PubMed ID: 20042453
    [No Abstract]   [Full Text] [Related]  

  • 4. Biobanking of CSF: international standardization to optimize biomarker development.
    Teunissen CE; Tumani H; Engelborghs S; Mollenhauer B
    Clin Biochem; 2014 Mar; 47(4-5):288-92. PubMed ID: 24389077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biobanking of Cerebrospinal Fluid.
    Tashjian RS; Vinters HV; Yong WH
    Methods Mol Biol; 2019; 1897():107-114. PubMed ID: 30539439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases.
    Willemse EA; Teunissen CE
    Adv Exp Med Biol; 2015; 864():79-93. PubMed ID: 26420615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers.
    Hok-A-Hin YS; Willemse EAJ; Teunissen CE; Del Campo M
    Methods Mol Biol; 2019; 2044():27-50. PubMed ID: 31432404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of biomaterials in liquid- and tissue-biobanking].
    Herpel E; Schmitt S; Kiehntopf M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):325-35. PubMed ID: 26753866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of cerebrospinal fluid in biomarker studies.
    Teunissen CE; Verheul C; Willemse EAJ
    Handb Clin Neurol; 2017; 146():3-20. PubMed ID: 29110777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in biobanking workflow standardization providing sample integrity and stability.
    Malm J; Fehniger TE; Danmyr P; Végvári A; Welinder C; Lindberg H; Appelqvist R; Sjödin K; Wieslander E; Laurell T; Hober S; Berven FS; Fenyö D; Wang X; Andrén PE; Edula G; Carlsohn E; Fuentes M; Nilsson CL; Dahlbäck M; Rezeli M; Erlinge D; Marko-Varga G
    J Proteomics; 2013 Dec; 95():38-45. PubMed ID: 23856607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for "Precision Medicine and Pharmacometabolomics Task Group"-The Metabolomics Society Initiative).
    Kirwan JA; Brennan L; Broadhurst D; Fiehn O; Cascante M; Dunn WB; Schmidt MA; Velagapudi V
    Clin Chem; 2018 Aug; 64(8):1158-1182. PubMed ID: 29921725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic principles of biobanking: from biological samples to precision medicine for patients.
    Annaratone L; De Palma G; Bonizzi G; Sapino A; Botti G; Berrino E; Mannelli C; Arcella P; Di Martino S; Steffan A; Daidone MG; Canzonieri V; Parodi B; Paradiso AV; Barberis M; Marchiò C;
    Virchows Arch; 2021 Aug; 479(2):233-246. PubMed ID: 34255145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Hansson O; Mikulskis A; Fagan AM; Teunissen C; Zetterberg H; Vanderstichele H; Molinuevo JL; Shaw LM; Vandijck M; Verbeek MM; Savage M; Mattsson N; Lewczuk P; Batrla R; Rutz S; Dean RA; Blennow K
    Alzheimers Dement; 2018 Oct; 14(10):1313-1333. PubMed ID: 29940161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biobanking as a necessary tool for research in the field of personalized medicine in the scientific medical center.
    Pokrovskaya MS; Sivakova OV; Efimova IA; Meshkov AN; Metelskaya VA; Shalnova SA; Drapkina OM
    Per Med; 2019 Nov; 16(6):501-509. PubMed ID: 31709888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biobanks and Their Clinical Application and Informatics Challenges.
    Yang L; Chen Y; Yu C; Shen B
    Adv Exp Med Biol; 2016; 939():241-257. PubMed ID: 27807750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population biobanking and international collaboration.
    Zawati MH; Knoppers B; Thorogood A
    Pathobiology; 2014; 81(5-6):276-285. PubMed ID: 25792216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization and Innovation in Paving a Path to a Better Future: An Update of Activities in ISO/TC276/WG2 Biobanks and Bioresources.
    Furuta K; Allocca CM; Schacter B; Bledsoe MJ; Ramirez NC
    Biopreserv Biobank; 2018 Feb; 16(1):23-27. PubMed ID: 29394084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-Assured Biobanking: The Leiden University Medical Center Model.
    Haumann R; Verspaget HW
    Methods Mol Biol; 2018; 1730():361-370. PubMed ID: 29363088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.
    del Campo M; Mollenhauer B; Bertolotto A; Engelborghs S; Hampel H; Simonsen AH; Kapaki E; Kruse N; Le Bastard N; Lehmann S; Molinuevo JL; Parnetti L; Perret-Liaudet A; Sáez-Valero J; Saka E; Urbani A; Vanmechelen E; Verbeek M; Visser PJ; Teunissen C
    Biomark Med; 2012 Aug; 6(4):419-30. PubMed ID: 22917144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
    Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
    Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.